Don i agree with your assessment and would add this along with many others here. most on this board research alot of biotechs. i for one can not really find another biotech with aria marketcap with good results of phase 3 drug. a second drug that has steller results so far and has the potential to be blockbuster and we own 100 percent of it. and a 3rd drug ready to start testing.
so i ask other aria longs what would we put our money into. ARIA imho at this price or 7.32 still offers the best potential/risk biotech that i know of going forward over the next 1-2 years??
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.